Purpose: To assess whether the radiomic features of diffusion tensor imaging (DTI) and conventional postcontrast T1-weighted (T1C) images can differentiate the epidermal growth factor receptor (EGFR) mutation status in brain metastases from non-small cell lung cancer (NSCLC). Methods: A total of 99 brain metastases in 51 patients who underwent surgery or biopsy with underlying NSCLC and known EGFR mutation statuses (57 from EGFR wild type, 42 from EGFR mutant) were allocated to the training (57 lesions in 31 patients) and test (42 lesions in 20 patients) sets. Radiomic features (n = 526) were extracted from preoperative MR images including T1C and DTI. Radiomics classifiers were constructed by combinations of five feature selectors and fou...
BACKGROUND AND PURPOSE: Epidermal growth factor receptor amplification is a common molecular event i...
Purpose: Considerable progress has been made in the assessment and management of non-small cell lung...
BackgroundThis study aimed to noninvasively predict the mutation status of epidermal growth factor r...
Identification of EGFR mutations is critical to the treatment of primary lung cancer and brain metas...
Lung cancer metastases comprise most of all brain metastases in adults and most brain metastases are...
BACKGROUND AND PURPOSE: Development of noninvasive imaging biomarkers indicating the histology and...
Purpose: Histopathological differentiation of primary lung cancer is clinically important. We aimed ...
PURPOSE: To evaluate whether diffusion tensor imaging (DTI) radiomics with machine learning improv...
We propose a novel framework for determining radiomics feature robustness by considering the effects...
RATIONALE AND OBJECTIVES: To compare differences in diffusion tensor imaging (DTI) and dynamic susce...
Background: Early diagnosis of brain tumors has significant effect on the treatment process. Brain m...
Background: To establish a radiomic approach to identify epidermal growth factor receptor (EGFR) mut...
Purpose: Non-small cell lung cancer (NSCLC) tends to metastasize to the brain. Between 10 and 60% of...
Background: Brain metastases are associated with poor survival. Molecular genetic testing informs on...
OBJECTIVES: To predict epidermal growth factor receptor (EGFR) mutation status using quantitative ra...
BACKGROUND AND PURPOSE: Epidermal growth factor receptor amplification is a common molecular event i...
Purpose: Considerable progress has been made in the assessment and management of non-small cell lung...
BackgroundThis study aimed to noninvasively predict the mutation status of epidermal growth factor r...
Identification of EGFR mutations is critical to the treatment of primary lung cancer and brain metas...
Lung cancer metastases comprise most of all brain metastases in adults and most brain metastases are...
BACKGROUND AND PURPOSE: Development of noninvasive imaging biomarkers indicating the histology and...
Purpose: Histopathological differentiation of primary lung cancer is clinically important. We aimed ...
PURPOSE: To evaluate whether diffusion tensor imaging (DTI) radiomics with machine learning improv...
We propose a novel framework for determining radiomics feature robustness by considering the effects...
RATIONALE AND OBJECTIVES: To compare differences in diffusion tensor imaging (DTI) and dynamic susce...
Background: Early diagnosis of brain tumors has significant effect on the treatment process. Brain m...
Background: To establish a radiomic approach to identify epidermal growth factor receptor (EGFR) mut...
Purpose: Non-small cell lung cancer (NSCLC) tends to metastasize to the brain. Between 10 and 60% of...
Background: Brain metastases are associated with poor survival. Molecular genetic testing informs on...
OBJECTIVES: To predict epidermal growth factor receptor (EGFR) mutation status using quantitative ra...
BACKGROUND AND PURPOSE: Epidermal growth factor receptor amplification is a common molecular event i...
Purpose: Considerable progress has been made in the assessment and management of non-small cell lung...
BackgroundThis study aimed to noninvasively predict the mutation status of epidermal growth factor r...